A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)
Clinical trial NCT05268952 · UNKNOWN
Trial details
- NCT number
- NCT05268952
- Sponsor
- University Hospital, Antwerp
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-27
- Primary completion
- 2025-05-27
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.